Clinical Trial Update: FOLFIRINOX Versus OncoSil™ in Addition to FOLFIRINOX in Patients With Locally Advanced Pancreatic Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial comparing FOLFIRINOX with and without OncoSil in locally advanced pancreatic cancer; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• FOLFIRINOX regimen (5-fluorouracil, leucovorin, oxaliplatin, irinotecan)
• OncoSil

Snippet

Sponsor: OncoSil Medical Limited | Conditions: Locally Advanced Pancreatic Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING